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Background: There has been increasing interest recently in the plasticity of mesenchymal stem cells (MSCs) and
their potential to differentiate into neural lineages. To unravel the roles and effects of different growth factors in
the differentiation of MSCs into neural lineages, we have differentiated MSCs into neural lineages using different
combinations of growth factors. Based on previous studies of the roles of insulin-like growth factor 1 (IGF-1) in
neural stem cell isolation in the laboratory, we hypothesized that IGF-1 can enhance proliferation and reduce
apoptosis in neural progenitor-like cells (NPCs) during differentiation of MSCs into NCPs.
We induced MSCs differentiation under four different combinations of growth factors: (A) EGF + bFGF, (B) EGF +
bFGF + IGF-1, (C) EGF + bFGF + LIF, (D) EGF + bFGF + BDNF, and (E) without growth factors, as a negative control.
The neurospheres formed were characterized by immunofluorescence staining against nestin, and the expression
was measured by flow cytometry. Cell proliferation and apoptosis were also studied by MTS and Annexin V assay,
respectively, at three different time intervals (24 hr, 3 days, and 5 days). The neurospheres formed in the four
groups were then terminally differentiated into neuron and glial cells.
Results: The four derived NPCs showed a significantly higher expression of nestin than was shown by the negative
control. Among the groups treated with growth factors, NPCs treated with IGF-1 showed the highest expression
of nestin. Furthermore, NPCs derived using IGF-1 exhibited the highest cell proliferation and cell survival among
the treated groups. The NPCs derived from IGF-1 treatment also resulted in a better yield after the terminal differentiation
into neurons and glial cells than that of the other treated groups.
Conclusions: Our results suggested that IGF-1 has a crucial role in the differentiation of MSCs into neuronal lineage by
enhancing the proliferation and reducing the apoptosis in the NPCs. This information will be beneficial in the long run for
improving both cell-based and cell-free therapy for neurodegenerative diseases.
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Stem cells are generally defined as immature cells with
self-renewal competencies and the capability of differen-
tiating into other cell types [1,2]. Stem cells may be
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unless otherwise stated.and because of their differential potential they may be
classified into two types: embryonic stem cells (ESCs)
and adult stem cells (ASCs) [3]. ESCs are pluripotent
cells derived from the inner cell mass of the blastocyst
[4], whereas ASCs are isolated from adult tissues and de-
fined as multipotent, since they are determined to pro-
duce cell types within their niche [5]. However, recent
studies suggested that ASCs, especially mesenchymal
stem cells (MSCs) derived from bone marrow (BM),
have intrinsic neurogenic potential and may be differen-
tiated into mature cells of ectodermal origin [6-8].
MSCs are also known as stromal cells and can be readily
isolated from bone marrow and expended in vitro. In fact,d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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as the umbilical cord, adipose tissue, peripheral blood, and
amniotic fluid [9-11]. The trans-lineage differentiation
capability and unique immunogenic properties of MSCs
have made them a potential alternative for cellular
transplantation use in regenerative medicine [12]. Au-
tologous transplantation of MSCs in stroke patients
was proven therapeutically effective [13].
Recent studies have demonstrated that chemokines such
as epidermal growth factor (EGF) and basic fibroblast
growth factor (bFGF) are crucial factors in the neurogenic
differentiation of MSCs [14,15]. Our previous study has
proved that a combination of EGF, FGF-2, and IGF-1 sig-
nificantly enhances long-term proliferation and survival of
rat striatal neural stem cells in vitro [16]. No analytical
studies that we know of have been undertaken to investi-
gate the effects of IGF-1 on neuronal induction of MSCs.Figure 1 Phenotypic analysis of bone marrow mesenchymal stem cel
the flask exhibiting elongation (arrow). (B) Homogenous rat BM MSCs at passag
(C-D) Immunofluorescence of BM MSCs showing a strong expression of CD90 (
Immunophenotypes of BM MSCs analysed by flow cytometry. Images w
and a fluorescence microscope equipped with a pseudo-fluorescence fiTherefore, the aim of this study was to analyse the role
of IGF-1 in comparison with other types of growth fac-
tors that focus on stage-specific differentiation of MSCs
into NPCs.
Results
Characterization of BM MSCs
BM MSCs have fibroblast-like morphology (Figure 1A)
and form whirlpool-like structures when grown to 80%
confluence (Figure 1B). Immunofluorescence staining
showed bright staining in all MSCs with antibodies
against CD90 (Figure 1C) and CD44 (Figure 1D). Only
5.15 ± 0.68% (n = 6) of cells expressed nestin (Figure 1E).
No staining was observed against markers of neuronal cell
types such as Sox-2, GFAP, and FluoroPan (data not
shown). Flow cytometry analysis further showed that BM
MSCs were positive for CD90 and CD44 (Figure 1F). BMls. (A) Primary rat bone marrow MSCs attached to the surface of
e 4 displaying a fibroblast-like appearance and spindle-like arrangement.
C) and CD44 (D). (E) BM MSCs showing weak expression of nestin. (F)
ere viewed at 400× magnification using an inverted microscope
lter.
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consistent morphology and phenotype. The phenotypic
analyses of the cells isolated are similar to those de-
scribed in Hong et al. [9], indicating that the BM MSCs
isolated for our experiment met the standard criteria
of mesenchymal stem cells.Figure 2 Neurospheres at days 1, 3, and 5 showing differing sizes in
Group B (EGF + bFGF + IGF-1); Group C (EGF + bFGF + LIF); Group D (EGF +
attached to the flask starting to differentiate (arrows). Neurospheres with ir
viewed with 100× magnification under an inverted microscope.Differentiation of BM MSCs into NPCs
Only the cells in Group E adhered to the surface of the
tissue culture plates (Figure 2); the others formed many
small spheres of floating cells after day 1 of induction.
MSC-derived NPCs proliferated for 1 week without chan-
ging morphology or phenotype. Immunofluorescencedifferent combination of growth factors. Group A (EGF + bFGF);
bFGF + BDNF) and Group E (no growth factors). Cells in Group E
regular shape formed in Group E on day 5 of culture. Images were
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bFGF + IGF-1) were strongly positive for nestin (Figure 3A)
and Sox-2 (Figure 3B). Moreover, data from flow cytometry
confirmed the findings of immunocytochemical analysis
(Figure 3C) and it also confirmed the expression of nestin
by NPCs derived from all groups. In the 10,000 events ac-
quired, 93.7% of the cells in Group B under IGF-1 treat-
ment expressed nestin, whereas 53.4% of the cells in Group
E expressed nestin and this expression might be due to the
effect from neurobasal media. These results indicate the
level of nestin-positive cells under the effect of the growth
factors.
Proliferation assays
To elucidate the effects of growth factors on prolifera-
tion of NPCs we investigated the growth of cells usingFigure 3 Immunocytochemical staining and flow cytometer analysis o
B (EGF + bFGF + IGF-1) strongly expressing nestin. (B) NPCs from group B also
NPCs from all groups (A, B, C and D) indicating the early differentiation of MSC
cells indicating partial differentiation due to the effect of neural basal m
from immunofluorescence staining for group B. Images were viewed atMTS assays at different time intervals (24 hr, 48 hr,
72 hr, 96 hr, and 120 hr) during the differentiation. Our
results showed that the treatment group with IGF-1 had
a significantly enhanced proliferation of NPCs at each
time interval (Figure 4). To validate these data, we per-
formed a one-way ANOVA across the groups. This dem-
onstrated that IGF-1 could maintain cell proliferation at
all time points (n = 12, p < 0.05). Our results were con-
sistent with the previous study by Supeno et al. [16],
which found that IGF-1 enhanced the proliferation of
neural stem cells. We also carried out multiple compari-
sons between the groups (Figure 5). These comparisons
clearly showed the effects of other growth factors in
maintaining cell proliferation and their significance in
differentiation activity. However, IGF-1 enhanced prolif-
eration in NPCs more than the other growth factors.f MSC-induced neural progenitor-like cells. (A) NPCs from group
strongly express Sox-2. (C) Flow cytometer analysis of nestin expression of
s into NPCs. Group E clearly show the existence of two populations of
edia. Flow cytometric data further validated the results obtained
100× magnification using a fluorescence microscope.
Figure 4 Proliferation analyses of NPCs under different growth factors. Cells (n = 12) were incubated with MTS reagent for 4 hr and
changes in proliferation were studied at five time intervals (24 hr, 48 hr, 72 hr, 96 hr, and 120 hr). The data represented as optical density (OD)
at 540 nm in mean ± SEM (p < 0.05).
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To understand the role of the combination of growth
factors on the survival of NPCs in vitro, we also studied
the apoptotic activity of NPCs at three time intervals
(24 hr, 72 hr, and 120 hr) using the Annexin V kit.
Immunofluorescence staining of NPCs revealed that the
differentiation process induces cellular apoptosis (Figure 6).
Apoptotic activities such as necrosis and early and late
apoptosis were quantified by flow cytometry. The group
treated with IGF-1 maintained the highest percentage of
live cells at day 3 post induction, 48.6 ± 19.5% (n = 3;
Figure 7A). Only 9.3 ± 7.6%, 0.5 ± 0.7%, and 1.3 ± 1.4%
(n = 3) of cells in Group B underwent necrosis at day 1, day
3 and day 5 respectively (Figure 7B). Furthermore, only
3.7 ± 3.3% of cells in Group B underwent early apoptosis.
The number increases to 24.6 ± 15% on day 3 and
decreases to 13 ± 11.5% on day 5 (Figure 7C). A total of
28.1 ± 15.05% of cells from Group B underwent late apop-
tosis, decreasing to 26.3 ± 14.3% on day 3 and furtherdecreasing to 15.6 ± 6.7% on day 5 (Figure 7D). Taken to-
gether, the early and late apoptosis graphs suggest that the
group treated with IGF-1 has better survival efficiency than
the rest of the groups.
Quantitative RT-PCR
Total RNAs were collected from each treatment group
3 days post induction, and real-time PCR validations
on neurofilament gene (NEFL) and nestin (NES) were
performed (Figure 8A). PCR reactions were normalised
by amplifying the same sample of cDNA with primers
against beta-Actin (ACTB). As expected, the treatment
group with IGF-1 (Group B) expressed the highest
level of nestin (p < 0.05, n = 3; Figure 8B), which was
significantly greater than the other groups. However,
the expression of the neurofilament gene did not show
any significant variation in any of the treated groups.
Our results suggest that IGF-1 maintains NPCs in an
undifferentiated state while sustaining the stemness.
Figure 5 Pairwise multiple comparison analyses between groups of NPCs at different time intervals. Pairwise multiple comparison
analysis was carried out using Tukey’s HSD (Tukey’s honest significant difference test). The data in red represents mean ± SD for statistically
significant results (p < 0.05). P-values stated in blue indicate statistically insignificant comparisons (p > 0.05).
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To assess the capability of NPCs to differentiate into
mature neuronal cell types in vitro, we used the protocol
suggested by Hermann et al. [14] with minor modifica-
tions. NPCs from groups A, B, C and D were plated in
medium without EGF and bFGF but with brain-derived
neurotrophic factor (BDNF) and platelet-derived growth
factor (PDGF). All the NPCs in the four groups differen-
tiated into mature neurons and glial cells. Cells attached
and changed their morphology on the following day
(Figure 9A-D). The cells from negative control, Group
E, were also treated similarly but the cells at the end did
not attach indicating no mature neural cells were formed
(Figure 9E). The neural cells types formed most effi-
ciently from the group B NPCs compared to other
groups (Figure 9B). These differentiated cells, from
group B NPCs, were further characterized with specific
markers. The cells were allowed to differentiate for
10 days with constant replacement of growth factors.
Differentiated cells were fixed in freshly prepared 4%
PFA in PBS, blocked, and stained with FluoroPan neur-
onal marker and Glial fibrillary acidic protein (GFAP).
We find it interesting that terminally differentiatedNPCs expressed the marker specific for neuronal pro-
tein (Figures 10A-D) which commonly express in ma-
tured neuronal bodies and also GFAP (Figure 10E), an
astrocytes marker. Moreover, differentiated cells also
showed the characteristics of mature neuronal and
glial cells. Thus our results have proved that NPCs
are capable of being differentiated into neurons and
astrocytes by specific cytokines supplementation. The
results clearly indicate the NPCs derived from the
group B were able to differentiate into mature neur-
onal phenotype.
Discussion
Adult stem cells, particularly mesenchymal stem cells,
have been used in neuro-regenerative medicine for the
treatment of diseases such as stroke and traumatic brain
injury [9]. The potential application of MSCs from
bench to bedside is due to their easy accessibility and ex-
pansion capability both in vivo and in vitro, and also
their ability to promote endogenous neurogenesis via a
variety of secretion factors. Autologous transplantation
of MSCs extracted from Wharton’s jelly has been re-
ported to be free from immunogenic rejection [18]. It
Figure 6 Apoptosis assay. Immunostaining revealed that transdifferentiation is associated with apoptotic activities. (A) SYTOX Blue nuclei
staining, (B) FITC-conjugated Annexin V, (C) propidium iodide (PI), and (D) overlay image. All images are viewed at 40× magnification under a
confocal microscope.
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lineage through several methods such as incubation
with cytokines [19], co-culture with nerve cells [1,6], and
transfection with known factors [20]. Recent evidence
has shown that synergistic treatment of MSCs with
bFGF and EGF significantly differentiates MSCs into
cells expressing neural lineage markers. Previous studies
in the laboratory have shown that addition of IGF-1
leads to enhanced embryonic striatal neural stem cell
proliferation in vitro [16]. In the present study, we have
demonstrated that the presence of IGF-1 enhanced prolifer-
ation and reduced apoptosis during the differentiation of
MSCs into NPCs.
Nestin, the intermediate filament protein, is predom-
inantly expressed during early neurogenesis and also
expressed in neural stem cells [7]. Immunofluorescence
staining of MSCs showed mild expression of nestin
(Figure 1E) consistent with the previous finding of
Wislet-Gendebien et al. [1] that nestin-positive MSCs
may differentiate in vitro into functional neuronal-like
cells. From recent studies it can be suggested that MSCs
have two populations: nestin positive and nestin nega-
tive [1]. Some research suggests that the MSCs express
the nestin when they are under stress [21,22]. However,
further research is warranted to characterise the twopopulations of the MSCs and trace their origins. In our
study, neurosphere formation was observed in all groups
except Group E, and the size of the neurospheres increased
every day (Figure 2), indicating that cell proliferation occurs
during the differentiation. The phenotype and morphology
of MSC-derived neurospheres in our study are similar to
that of embryonic striatal stem cells isolated previously in
the laboratory [16]. During the differentiation, nestin ex-
pression increases sharply (Figure 3C), and immunochemi-
cal staining showed that almost all the cells were positive
for nestin and Sox-2 after 5 days. This indicated that the
MSCs have switched from their original mesodermal
lineage into ectodermal and started differentiate into more
lineage specific cells such as neurons or astrocytes. Flow cy-
tometry analysis of Group E (Figure 3C) clearly showed that
without growth factors a few MSCs were differentiated into
NPCs. This differentiation may be due to either the effect
of neural basal media or in vitro stress. The nestin expres-
sion was highest in the NPCs derived from IGF-1, indicat-
ing that the growth factor enhances the proliferation of
NPCs during the differentiation of MSCs into NPCs. We
investigated the proliferation activity of each group due to
the effect of the respective growth factors. Our result
strongly corroborated with the previous finding that IGF-1
treatment could significantly enhance proliferation of NPCs
Figure 7 Comparison of apoptotic activities between groups (n = 3). (A) Percentage of live cells. (B) Percentage of necrotic cells. (C)
Percentage of early apoptotic cells. (D) Percentage of late apoptotic cells. The data are presented as mean ± SD for statistically significant results
(p < 0.05) and were obtained by flow cytometry equipped with analytical software.
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stages of neuronal differentiation, a proliferation assay was
carried out in a stage-specific approach on passage 1 at five
different time intervals. We hypothesized that the cells
would undergo apoptosis at day 2 and start to stabilise atFigure 8 Quantitative RT-PCR analysis (n= 3). (A) Expression plots of the ne
gene (orange). (B) Histograms showing quantification of NES and NEFL at the inday 3 post-induction. This is consistent with the previous
finding that one third of MSCs died after induction [14].
IGF-1 has mitogenic effects by promoting G1/S cell cycle
progression through Akt-dependent and tyrosine kinase–
signalling pathways [23-25]. These signalling pathwaysstin gene (green), the neurofilament gene (red) and the housekeeping
dicated time. Results are expressed as the mean ± SD. *p< 0.05.
Figure 9 In vitro differentiation of NPCs into neuronal cell types. NPCs from group A, B, C and D were differentiated at day 3 post induction using
glial induction and neuronal induction protocol on poly-L-lysine coated wells for 14 days. All the NPCs from the four groups differentiated, attached to the
surfaces and changed their morphology. The cells from negative control, Group E, were also treated similarly but the cells at the end of differentiation did
not attach indicating no mature neural cells were formed.
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NPCs formed will proliferate efficiently in the presence
of IGF-1 [22]. We also carried out intergroup compari-
sons, and the data was presented in checkbox format
(Figure 5). Our data has clearly indicated that IGF-1
has positive regulatory effects in maintaining cellular
propagation of NPCs in neuronal differentiation.
MSCs may even release certain neurotrophic factors
such as BDNF, nerve growth factor, and glial-derived
neurotrophic factors [26,27], and it is well known that
the neurotrophic factors are important for maintaining
cellular survival of neuronal cells both in vitro and
in vivo. Immunochemistry showed that neurospheres
from all groups undergo qualitatively similar apoptosis
(Figure 6). Therefore, we proceeded to quantitative ana-
lysis using flow cytometry, and the data were presented
in four different graphs, which indicated the percentages
of live cells, necrotic cells, and early and late apoptotic
cells (Figure 7). Cells treated with IGF-1 showed gener-
ally better cell survival, maintaining a higher percent-
age of live cells and a lower percentage of both
necrotic and apoptotic cells during differentiation.
Moreover, our results also suggested that since MSCs
could self-secrete BDNF, which is crucial for neuropro-
tection, and our findings show that IGF-1 promotes
better survivability than those induced under BDNF in-
fluence alone (Group D). We suggest that IGF-1 might
interact with BDNF to promote better enhancement of
terminal differentiation.Results of both proliferation and apoptosis have led us
to conclude that NPCs achieve optimal condition 3 days
post induction. Thus we investigated the quantity of nes-
tin and neurofilament genes expressed at day 3 from all
groups. Our results showed that the group treated with
IGF-1 expressed the highest nestin level of all groups.
This indicated that IGF-1 effectively maintains the stem-
ness of the neural progenitor cells and the combination
of the growth factors maintains the cells in an undiffer-
entiated stage; our findings support those in the previous
study by Chang et al. [28].
Furthermore, we successfully differentiated neuro-
spheres from all groups into cells that expressed neur-
onal markers and astrocytes (GFAP; Figures 9 and 10).
Thus, our neurospheres induced from MSCs are self-
proliferating cells that maintain the capacity to differ-
entiate into mature brain cells.
We differentiated neurospheres from each group accord-
ing to Hermann et al. [14]. Neurospheres from all groups
terminally differentiated into cells with a neuronal pheno-
type. The neural phenotype (mature brain cells) formed
from neurospheres treated with IGF-1 are shown in the
Figure 9. The terminal differentiation of neurospheres in
the group B was most efficient compared to other three
groups. Thus our results showed clearly that the combin-
ation of growth factors EGF + FGF-2 + IGF-1 enhances pro-
liferation and reduces the apoptosis in the NPCs during the
differentiation of MSCs into neural lineages. The IGF-1
treatment produced healthier and more functional neural
Figure 10 Immunocytochemical staining of terminally differentiated cells. NPCs from group B were differentiated using the neuronal
induction medium and were stained with FluoroPan neuronal marker for neurons and astrocytes (GFAP). Nuclei have been counterstained with
SYTOX Blue. (A) Phase contrast image of differentiated cells. (B) FluoroPan neuronal FITC. (C) Nucleus staining with SYTOX Blue. (D) Overlay
image. (E) Astrocytes stained with GFAP and counterstained with secondary antibody Cy3. Images were taken at 400× magnification using a
Pascal 5 confocal microscope (Carl Zeiss, Germany).
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growth factors tested.
Conclusion
We conclude that IGF-1 is an important growth factor
for enhancing proliferation and inhibiting apoptosis of
neural progenitor-like cells during differentiation of
MSCs into neural lineages. Further, IGF-1 enhances nes-
tin expression. These enhancements might be due to the
activation of tyrosine kinase– and PI3 kinase–signalling
pathways, which are mediated by the IGF-1 growth fac-
tor [23-25]. These pathways activate proliferation and in-
hibit apoptosis in the NPCs. This information will be
beneficial for future improvements in both cell-based
and cell-free therapy for neurodegenerative diseases.
Methods
Animals
Sprague Dawley (SD) rats 4–6 weeks old were ob-
tained from the Animal Research and Service Centre
(ARASC, Universiti Sains Malaysia, Health Campus).Housing and breeding of the rats were taken care of in
intramural facilities. The animal ethics clearance for all
experimentation was obtained from the USM Animal
Ethics Committee.
BM MSC cultures
The SD rats were euthanized by intra-peritoneal injec-
tion of an overdose of ketamine (100 mg/ml) and xyla-
zine (100 mg/ml) from Ilium Troy Laboratory, Australia.
Femoral and tibiae bones were then dissected aseptically.
The central canal of the bone was injected with 5 ml of
Dulbecco’s Modified Eagle’s Medium (DMEM, catalog #
11885–084, Gibco, Life Technologies, USA) containing
20% (v/v) fetal bovine serum (FBS, catalog # 10270098,
Gibco, Life Technologies, USA), 1% MEM Non-essential
amino acid (Catalog # M7145, Sigma-Aldrich, USA) and
1% Antibiotic-antimycotic (Catalog # 15240062, Gibco,
Life Technologies, USA) to extrude the marrow tissue.
Then the tissue was gently dissociated into single cells
mixture and layered onto a Ficoll-Paque PREMIUM gra-
dient solution (Catalog # 17544202, GE Healthcare Bio-
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20 min. Mononuclear cells were extracted and plated on
T25 cm2 tissue culture flasks at a density of 1 × 107 mar-
row cells and incubated in a humidified chamber at 37°C
with a 5% CO2 supply. After 24 hours the non-adherent
cells were removed by total media replacement, and the
attached cells were grown. When the MSCs became 80%
confluent, they were detached with 0.25% trypsin/EDTA
and then subcultured. BM MSCs were characterised by
flow cytometry, and neuronal induction was conducted
at passage 4.
In vitro differentiation of BM MSCs into neural-like cells
The differentiation protocols used in this study were
modified from Supeno et al. [16]. BM MSCs were disso-
ciated with 0.25% trypsin-EDTA and reseeded into an
Ultra-Low Attachment 24-wells plate (Catalog # C62-
3473, Corning, USA) at a concentration of 1 × 105 cells/
cm2 in NeuroCult® NS-A proliferation media specific
for rat (Catalog # 05771, STEMCELL Technologies,
Canada). The cells were then supplemented with four
different combinations of growth factors. In accordance
with the study design, the BM MSCs were cultured in
five experimental groups: Group A (EGF + bFGF), Group
B (EGF + bFGF + IGF-1), Group C (EGF + bFGF + LIF),
Group D (EGF + bFGF + BDNF), and the negative con-
trol, Group E (no growth factor). All groups of cells were
maintained in the incubator at 37°C with a 5% CO2 sup-
ply. On the second and fourth day of cell culture, 50% of
the media was replaced and fresh growth factors were
added. Rate of cell proliferation and cell death of the
neurospheres formed were analysed after three time in-
tervals (24 hr, 3 days, and 5 days) of in vitro culturing.
Induction of terminal neural differentiation was then initi-
ated according to Hermann et al. [14], with minor modifi-
cation. The neurospheres were plated on glass slides coated
with poly-D-lysine, 10–20 neurospheres per ml of
NeuroCult® supplemented with 10 ng/ml PDGF-BB
recombinant mouse protein (Catalog # PMG0043, Invi-
trogen, USA) for glial induction or 10 ng/ml rh-BDNF
(Catalog # GF029, Chemicon International, Millipore,
USA) for neuronal differentiation. Cells were differentiated
for 14 days and media was changed every week with growth
factors supplementation every 2 days.
Immunocytochemistry characterization
The BM MSC and neurosphere phenotypes were deter-
mined by immunological labelling. Cells were fixed in 4%
paraformaldehyde in PBS for 10 min at room temperature
and blocked with a solution containing 5% of bovine
serum albumin in PBS and 0.05% Triton X-100 for cell
permeabilization. Immunocytochemistry was carried out
according to standard protocols. Cell nuclei were counter-
stained with SYTOX® Blue nucleic acid stain (1:1000;Invitrogen, USA). The antibodies used and dilution were
as follows: Anti-CD90 (FITC) conjugated mouse mono-
clonal antibody (1:200; Thermo Scientific, USA); Anti-
CD44 (PE) conjugated rat monoclonal antibody (1:200;
Abcam, Cambridge, UK) [17]; Alexa Fluor® 647 mouse
anti-nestin (1:200; BD Pharmingen, USA); Milli-Mark™
FluoroPan neuronal marker (1:100; Catalog # MAB2300X,
Millipore, USA); Anti-Sox-2 clone 6G1.2 FITC conjugated
antibody (1:100; Millipore, USA); Rabbit anti-GFAP (1:100;
Millipore, USA) and donkey anti-rabbit IgG-FITC second-
ary antibody (1:250; Santa Cruz Biotechnology, Inc, USA).
UltraCruz™ anti-fading mounting medium (Catalog # Sc-
24941, Santa Cruz Biotechnology, Inc, USA) was applied
to minimise photo bleaching due to exposure to high-
intensity light. The fixed cells were then viewed using a Pas-
cal 5 confocal microscope (Carl Zeiss, Germany).
Flow cytometric analysis
Nestin expression of MSC-derived NPCs was quantified
by flow cytometry analysis. Neurospheres at different
time intervals were dissociated into single cells using a
solution of Detachin (Catalog # T100100, Genlantis,
USA). Next, the cells were permeabilized and incubated
with Alexa Fluor® 647 mouse antibody against nestin on
ice for 1 hr. A FACSCanto flow cytometry machine
equipped with FACSDiva analytical software (BD Bio-
science, USA) was used for analysing the percentage of
nestin-positive cells. A minimum of 10,000 events was
acquired for each sample. Forward and side light-scatter
gates were set to exclude debris and clumps of cells.
Proliferation study
Proliferation studies were performed using CellTiter 96®
Aqueous One Solution cell proliferation assay (Catalog #
G3580, Promega, USA). BM MSCs were seeded in 96-
wells cell culture plates (1000 cells/well) within the re-
spective neuronal induction media (Group A: EGF +
FGF-2; Group B: EGF + FGF-2 + IGF-1; Group C: EGF +
FGF-2 + LIF; Group D: EGF + FGF-2 + BDNF; and Group
E: without growth factor). On the first, third, and
fifth days of culture, cells were incubated with 3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium (MTS) reagent at 37°C for
4 hours, and absorbance was measured using a spectro-
photometer at wavelength 490 nm.
Apoptosis assay
Apoptotic activity due to neuronal induction was assessed
using Annexin V stain (Catalog # 556547, BD Pharmingen,
USA). Neurospheres from each group were gently dissoci-
ated into single-cell format, resuspended in 1X binding buf-
fer, and then incubated with FITC-conjugated Annexin V
and propidium iodide for 15 minutes, according to the
manufacturer’s recommended protocol. Apoptotic activity
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tive results were obtained by flow cytometry analysis.
RNA extraction and quantitative real-time PCR analysis
Total cellular RNAs were extracted from neurospheres
of each group using the miRNeasy Mini Kit (Catalog #
217004, Qiagen, Germany). Next, reverse transcription
was performed on up to 2ug of the total RNA using the
High Capacity RNA-to-cDNA Kit (Catalog # 4387406,
Applied Biosystems, USA) as directed by the manufacturer.
The expressions of nestin and neurofilament genes were
determined by the TaqMan® Real-Time PCR system (Ap-
plied Biosystems, USA). Predesigned primer and amplicons
length were as follows: nestin (NES): Rn00564394m1, 78;
neurofilament (NEFL): Rn00582365m1, 65; and the house-
keeping gene beta-Actin (ACTB): Rn00667869m1, 91. Real-
time quantitative analysis was carried out using the 7500
Real-Time PCR system (Applied Biosystems, USA) and
amplification was monitored and analysed by 7500 software
version 2.0.6 (Applied Biosystems, USA).
Statistical analysis
Statistical analysis was carried out using IBM SPSS Sta-
tistics Software version 20. Results were analysed for
statistical significance using a two-way ANOVA for dif-
ferent time intervals: day 1, day 3, and day 5. All data
unless specified are expressed as the mean plus or minus
the standard deviation. Values of p less than 0.05 were
considered statistically significant.
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